Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Standard BioTools Sees FY2025 Sales $165.000M-$175.000M vs $186.93M Est

Author: Benzinga Newsdesk | February 26, 2025 04:11pm

Standard BioTools (NASDAQ:LAB) sees FY2025 sales of $165.000 million-$175.000 million vs $186.93 million analyst estimate.

Posted In: LAB